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ABSTRAK
Latar belakang: bersihan laktat dan saturasi oksigen vena sentral (ScvO2) adalah dua metode untuk 
menentukan kecukupan oksigenasi jaringan. Di antara kedua metode tersebut, terdapat kontroversi metode yang 
lebih berhubungan dengan dan dapat memprediksi mortalitas pasien sepsis dan renjatan sepsis. Penelitian ini 
bertujuan untuk menilai hubungan pencapaian target parameter akhir resusitasi mikrosirkulasi dan mortalitas 
dini pasien sepsis dan renjatan sepsis. Metode: penelitian ini merupakan studi kohort pada pasien sepsis dan 
renjatan sepsis dewasa di Unit Perawatan Intensif RS Cipto Mangunkusumo, Indonesia. Data parameter akhir 
resusitasi dan luaran pasien diamati dalam 120 jam pertama perawatan. Analisis Cox’s proportional hazard 
regression digunakan untuk menilai risiko mortalitas dini pada kelompok subjek yang mencapai target bersihan 
laktat saja, target ScvO2 saja, kedua target dan tidak mencapai target apapun dalam 6 jam pertama sesudah 
awitan resusitasi, dengan penyesuaian terhadap jumlah disfungsi organ. Hasil: subjek terdiri atas 268 pasien. 
Terdapat perbedaan risiko mortalitas yang bermakna antara kelompok subjek yang mencapai kedua target 
dibandingkan kelompok subjek yang mencapai target ScvO2 saja (adjusted hazard ratio [aHR] 13,47; 95% 
interval kepercayaan [IK] 5,17-35,08) dan yang tidak mencapai target apapun (aHR 16,12; 95% CI 7,43-34,95). 
Tidak terdapat perbedaan risiko mortalitas yang bermakna antara kelompok subjek yang mencapai kedua target 
dibandingkan kelompok subjek yang mencapai target laktat saja (aHR 2,29; 95%CI 0,83-6,32). Kesimpulan: 
pada pasien sepsis dan renjatan sepsis, pencapaian target bersihan laktat dan ScvO2 berhubungan dengan risiko 
mortalitas dini yang tidak berbeda dengan dengan pencapaian target bersihan laktat saja, namun berhubungan 
dengan peningkatan risiko mortalitas dini dibandingkan dengan pencapaian target bersihan ScvO2 saja.
Kata kunci: bersihan laktat, mortalitas dini, renjatan sepsis, saturasi oksigen vena sentral, sepsis.
ABSTRACT
Background: lactate clearance and central venous oxygen saturation (ScvO2) are two methods for determining 
tissue oxygenation adequacy. There is a controversy regarding method better associates with and predicts sepsis and 
septic shock patients’ mortality. This study address the association of achieving one or two targets of microcirculatory 
resuscitation endpoints and early mortality in sepsis and septic shock. Methods: a cohort study was conducted in 
adult sepsis and septic shock patients in Intensive Care Unit, Cipto Mangunkusumo Hospital, Indonesia. Patients’ 
resuscitation endpoints data and outcome were observed during the first 120 hours of hospitalization. Cox’s 
proportional hazard regression analysis was used to analyse the early mortality risk in subject groups achieving 
lactate clearance target only, ScvO2 target only, both targets, and not achieving any target in 6 hours after onset 
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of resuscitation adjusted for number of organ dysfunction. Results: subjects consisted of 268 patients. There were 
significant differences in the mortality risk between subjects who achieved both targets with subjects who achieved 
ScvO2 target only (adjusted hazard ratio [aHR] 13.47; 95% confidence interval [CI] 5.17-35.08) and subjects who 
not achieve any target (aHR 16.12; 95%CI 7.43-34.95). There were insignificant difference the early mortality 
risk between subjects who achieved both targets with subjects achieved lactate clearance target only (aHR 2.29; 
95%CI 0.83-6.32). Conclusion: in patients with sepsis and septic shock, achievement of lactate clearance and 
ScvO2 targets associates with similar early mortality risk compared to achievement of lactate clearance target 
only. However, it associates with lower early mortality risk compared with ScvO2 target only.
Keywords: central venous oxygen saturation, early mortality, lactate clearance, septic shock, sepsis.
INTRODUCTION
New guidelines on sepsis definition by 
a task force of sepsis expert proposed the 
presence of acute organ dysfunction in patient 
with infection as a key determinant of defining 
sepsis.1, 2 In accordance with this new guidelines, 
international guidelines for management of sepsis 
and septic shock in 2016 redefined sepsis-induced 
hypoperfusion as manifestation of acute organ 
dysfunction and/or hypotension and increment 
of serum lactate. In this population, initial 
resuscitation is strongly recommended.3 These 
two new definitions reflect the role of perfusion 
alteration (i.e. hypoperfusion) as pathophysiology 
hallmark of septic patient.
Hypoperfusion in sepsis does not only 
manifest as alteration of macrocirculation 
hemodynamic parameter (i.e. overt septic shock), 
but also with alteration of microcirculation 
hemodynamic parameter (i.e. cryptic septic 
shock) without alteration of macrocirculation 
hemodynamic parameter. Microcirculation 
end points resuscitation have gained many 
attentions since achievements of microcirculation 
resuscitation endpoints only could not improve 
septic patients’ survival.4-7 Lactate clearance 
>10% and central venous oxygen saturation 
(ScvO2) >70% are two methods for determining 
microculation hemodynamic adequacy. Optimal 
resuscitation should be targeted on both macro- 
and microcirculation resuscitation endpoints. 
By achieving these resuscitation endpoints, 
improvement of organ dysfunction and hence 
survival can be achieved.8-12
Approach on resuscitation using early goal-
directed therapy has been challenged by several 
newer trials, doubting the role of ScvO2 as essential 
microcirculation resuscitation endpoint.13-15 In 
response to these new evidences, Surviving 
Sepsis Campaign revised the sepsis bundles by 
eliminating the routine measurement of ScvO2 to 
be completed within 6 hours of presentation time. 
Lactate clearance is the only microcirculation 
endpoint in resuscitation that is recommended 
to be routinely measured.3,16 While there is a 
study revealing a non-inferiority of using lactate 
clearance compared to ScvO2 as resuscitation 
endpoint, there is no study comparing survival 
benefit of achievement of both microcirculation 
endpoints resuscitation with either one of the 
microcirculation resuscitation endpoint.9 This 
study was aimed to address the association of 
achieving one or two target of microcirculatory 
resuscitation endpoints (i.e. lactate clearance 
>10% and ScvO2 >70%) and early mortality in 
sepsis and septic shock patients.
METHODS
This was a cohort study using medical 
record from the Intensive Care Unit of Cipto 
Mangunkusumo Jakarta, Indonesia in 2013. 
Intensive Care Unit patients who met the third 
international consensus definitions for sepsis and 
septic shock (sepsis-3), aged 18 years and older 
were included.
Sepsis was defined as an acute change in 
>2 organ dysfunction caused by infection, 
while septic shock was defined as persistent 
hypotension requiring vasopressors to maintain 
mean arterial pressure (MAP) >65 mmHg and 
serum lactate >2 mmol/L despite adequate 
fluid resuscitation in sepsis patients.1 Subjects’ 
baseline (demographic, clinical) characteristics, 
macro- and microcirculation resuscitation 
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endpoints in 6 hours after onset of resuscitation, 
first 120 hour outcomes and time to outcome were 
recorded. The endpoints in resuscitation recorded 
were central venous pressure (CVP), MAP, urine 
output, hematocrit (Ht), ScvO2, lactate clearance, 
standard base excess (SBE), and number of 
organ dysfunction. Lactate clearance was 
calculated using the formula: [(pre-resuscitation 
lactate concentration – post-resuscitation 
lactate concentration) / pre-resuscitation lactate 
concentration] x 100%.10 The first 120 hours is 
the defining time for early mortality in sepsis 
used in this study, based on definition used on 
previous sepsis study, Recombinant Human 
Activated Protein C Worldwide Evaluation in 
Severe Sepsis.17
Subjects were then classified based on 
resuscitation of microcirculation resuscitation 
endpoints in 6 hours after onset of resuscitation 
into four groups, i.e. subject groups achieving 
lactate clearance >10% only, ScvO2 >70% only, 
both targets, and not achieving any target.
The sample size of the study was calculated 
based on an estimated 57% prevalence of 
subjects who achieved lactate clearance >10% 
and ScvO2 >70%. Assuming a relative hazard of 
1.5, with α = 0.05, β = 0.20 and early mortality 
prevalence 34%, the required total sample size 
was calculated to be 268 patients.18,19
Cox’s proportional hazard regression analysis 
was used to analyse the risk of early mortality in 
groups achieving lactate clearance target only, 
ScvO2 target only, both targets, and not achieving 
any target in 6 hours after onset of resuscitation. 
The adjusted hazard ratios were derived from 
multivariate Cox’s proportional hazard models 
adjusted for number of organ dysfunction, in 
accordance with conclusion of previous study 
reported that microcirculation end points of 
resuscitation and number of organ dysfunction 
were the predictors for early mortality in severe 
sepsis and septic shock patients.20-24 Statistical 
analyses were performed using the SPSS software 
version 20.0 (IBM Corp., USA). This study had 
been approved by the Ethics Committee of The 
Faculty of Medicine Universitas Indonesia with a 
reference number 025/H2.F1/ETIK/2013.
RESULTS
A total of 268 sepsis and septic shock patients 
were enrolled in this study. Subjects had a median 
age of 49 (interquartile range 25) years old, and 
147 (54,9%) were men. The majority of subjects 
achieved both microcirculation target (51.49%). 
The characteristics of subjects are presented in 
Table 1. The subject’s achievements of endpoints 
Table 1. Sepsis and septic shock subjects: comparison based on achievement of microcirculation resuscitation endpoints 
in 6 hours after onset of resuscitation
Variables




LC target only 
(n=54)
Group achieving 
ScvO2 target only 
(n=16)
Group not achieving 
any target
(n=60)
Sex (n, male/female) 72/66 33/21 11/5 31/29
Age (years)a 49.5 (26) 48 (26) 51 (21) 50.5 (27)
Septic shock (n, %) 72 (52.2) 24 (44.4) 11 (68.8) 45 (75)
Comorbidity (n, %)
 - Chronic heart failure 18 (13.04) 6 (11.11) 5 (31.25) 11 (18.33)
 - Chronic kidney disease, 
routine dialysis 5 (3.62) 3 (5.56) 1 (6.25) 11 (18.33)
 - Cerebrovascular disease 17 (12.32) 8 (14.81) 1 (6.25) 8 (13.33)
 - Hepatic cirrhosis 7 (5.07) 0 0 1 (1.67)
 - Malignancy 60 (43.48) 14 (25.92) 4 (25) 22(36.67)
 - Diabetes mellitus 33 (23.91) 23 (42.59) 4 (25) 21 (35)
Location of infection (n, %)b
 - Intracranial 7 (5.07) 2 (3.7) 0 3 (5)
 - Respiratory tract 92 (66.67) 36 (6.67) 12 (75) 41 (68.33)
 - Intra-abdominal and 
gastrointestinal tract 41 (29.71) 13 (24.07) 6 (37.5) 24 (40)
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Table 1. Sepsis and septic shock subjects: comparison based on achievement of microcirculation resuscitation endpoints 
in 6 hours after onset of resuscitation (continued)
Variables




LC target only 
(n=54)
Group achieving  
ScvO2 target only 
(n=16)
Group not achieving 
any target
(n=60)
 - Genito-urinary tract 11 (7.97) 3 (5.56) 1 (6.25) 7 (11.67)
 - Skin and soft tissue 20 (14.49) 11 (20.37) 4 (25) 9 (15)
Source of infection (n, %)b
 - Community 88 (63.77) 34 (62.96) 14 (87.5) 39 (65)
 - Nosocomial 54 (39.13) 23 (42.6) 4 (25) 23 (38.33)
Organ dysfunction based on SOFA (n, %)b
 - Respiration 100 (72.5) 44 (81.48) 14 (87.5) 52 (86.7)
 - Coagulation 39 (28.26) 14 (25.92) 8 (50) 31 (51.67)
 - Cardiovascular 73 (52.9) 23 (42.59) 12 (75) 45 (75)
 - Kidney 33 (23.91) 15 (27.78) 5 (31.25) 33 (55)
Number of organ dysfunction based on SOFA (n, %)
 - 1 organ dysfunction 60 (43.47) 23 (42.59) 4 (25) 7 (11.67)
 - 2  organ dysfunctions 40 (29) 16 (29.63) 4 (25) 18 (30)
 - More than two organ 
dysfunctions
38 (27.53) 15 (27.78) 8 (50) 35 (58.33)
Early mortality (n, %) 8 (5.79) 7 (12.96) 9 (56.25) 46 (76.67)
a data presented as median (interquartile range); b subjects fulfill multiple variables were calculated more than once; 
Abbreviation: LC: lactate clearance, SOFA: Sequential Organ Failure Assessment
Table 2. Subject’s achievements of endpoints in resuscitation within 6 hours after onset of resuscitation
End points 
resuscitation
Group achieved LC 
and ScvO2 target
(n=138)
Group achieved LC 
target only (n=54)
Group achieved  
ScvO2 target only 
(n=16)
Group not achieved 
any target (n=60)
Central venous pressure (n, %)
 - 8-12 mmHg 46 (33.34) 15 (27.78) 5 (31.25) 24 (40)
 - <8 mmHg 85 (61.59) 36 (66.67) 9 (56.25) 32 (53.33)
 - >12 mmHg 7 (5.07) 3 (5.55) 2 (12.5) 4 (6.67)
Mean arterial pressure (n, %)
 - >65 mmHg 124 (89.85) 46 (85.18) 11 (68.75) 45 (75)
 - <65 mmHg 14 (10.05) 8 (14.82) 5 (31.25) 15 (25)
Urine output (n, %)
 - >0,5 mL/kg/hour 127 (92.03) 49 (90.74) 11 (68.75) 36 (60)
 - <0,5 mL/kg/hour 11(7.97) 5 (9.26) 5 (31.25) 24 (40)
Hematocrit (n, %)
 - >30 % 138 (100) 54 (100) 0 0
 - <30% 0 0 16 (100) 60 (100)
Standard base excess (n, %)
 - >-2 mmol/L 66 (47.83) 34 (62.96) 6 (37.5) 15 (25)
 - -2 to -5,9 mmol/L 36 (26.09) 7 (12.96) 4 (25) 18 (30)
 - -6 to -14,9 mmol/L 32 (23.18) 12 (22.22) 5 (31.25) 22 (36.67)
 - <-15 mmol/L 4 (2.9) 1 (1.86) 1 (6.25) 5 (8.33)
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in resuscitation are presented in Table 2.
Risk of Early Mortality in Subject Groups
Outcome of the subjects are presented in 
Table 3. Cox’s proportional hazard regression 
analysis showed that subjects achieving both 
targets (lactate clearance and ScvO2) had the 
lowest risk of early mortality with hazard ratio 
(HR) 14.99; 95% confidence interval (CI) 5.77-
38.9 (p<0.001) compared to subjects who did not 
achieve ScvO2 target only and HR 23.43; 95%CI 
10.98-50.04 (p <0.001) compared with subjects 
not achieved any target. We found insignificant 
risk difference between subjects who achieved 
both targets with subjects who achieved lactate 
clearance target only (HR 2.32; 95%CI 0.84-6.40, 
p=0.104).
We adjusted the hazard ratio for number of 
organ dysfunction and found a significant risk 
difference between subjects who achieved both 
targets with subjects who achieved ScvO2 target 
only (adjusted HR 13.47; 95% CI 5.17-35.08, 
p<0.001) and subjects who did not achieve any 
target (adjusted HR 16.12; 95%CI 7.43-34.95, p 
<0.001). We found insignificant risk difference 
between subjects who achieved both targets with 
subjects who achieved lactate clearance target 
only (adjusted HR 2.29; 95% CI 0.83-6.32, 
p=0.109) (Figure 1).
In sub group analysis of 70 subjects who 
achieved either lactate clearance or ScvO2 target, 
failure to achieve lactate clearance target was 
associated with higher risk of early mortality 
(adjusted HR 5.92; 95% CI 2.18-16.01).
DISCUSSION
This is the first Indonesian study to assess 
the association of achieving one or two target 
of microcirculatory resuscitation endpoints (i.e. 
lactate clearance and ScvO2) and early mortality 
in sepsis and septic shock patients. For the 
Table 3. Outcome of sepsis and septic shock subjects
Variables












Early mortality (n, %) 8 (5.79) 7 (12.96) 9 (56.25) 46 (76.67)
Mean of survival (hours, 95%CI) 116.1 (112.8-119.3) 113.2 (106.4-120.1) 77.5 (55.4-99.6) 74.1 (64-84.2)
Figure 1. Survival analysis of groups based on targets achievement
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determination of cut off period in defining early 
mortality in this study, we referred to the result 
of previous study that divided mortality in sepsis 
patients into 4 periods. Mortality in the first fifth 
day of sepsis was defined as early mortality. 
There was different subjects’ characteristics and 
cause of death in the early and late mortality 
periods. Early mortality was related with number 
and degree of organ dysfunction, while late 
mortality was related with number and degree 
of comorbidities. The differences were also 
found in the biochemical analysis. In the early 
mortality group, there was increased level of 
Interleukin (IL)-6 and decreased circulating 
leucocyte; while in the late mortality group, 
there was decreased level of IL-6 and increased 
level of various inflammatory cytokines, i.e. 
Macrophage Inflammatory Proteins (MIP)-2, 
Monocyte Chemoattractant Protein (MCP)-1, 
IL-1 Receptor Antagonist (IL-1ra), and Soluble 
Tumor Necrosis Factor Receptor Type I (TNF-
SRI), and leucocytes reflecting the role of 
inflammation as the core pathophysiology of late 
mortality in sepsis.17, 25,26
The basic of organ dysfunction in sepsis 
is perfusion alteration. Thus, for decades it 
has been realized that the important strategy 
to increase survival of septic patients is by 
optimizing patients’ perfusion, both macro- and 
microcirculation, by adequate initial resuscitation 
using several resuscitation endpoints. Two of 
microcirculation resuscitation endpoints, i.e. 
lactate clearance and ScvO2, that were used in 
this trial was the widely accepted and studied 
targets.8-11,27,28 However, there is scarcity in 
trial that studied the potential benefit of using 
combination of both parameters compared 
to using either parameter. A study by Ali, 
et al29 showed that using those combination 
parameters do not predict mortality in ICU 
patients. In contrast to our study, this study 
was not exclusively done in septic patients and 
use all ICU mortality as the target outcome, 
not specifically studied early mortality period 
when perfusion alteration is the most prominent 
pathophysiology of death.
The subjects’ characteristic in the Table 
1 showed no difference on demographic 
characteristic, comorbidity, location and source 
of infection between subjects in four groups. 
There is a tendency of differences in number 
of organ dysfunction based on SOFA, with 
increasing number of organ dysfunctions in 
subjects that did not achieve lactate clearance 
target. Previous study revealed that number of 
organ dysfunction and lactate clearance are two 
predictors of early mortality in severe sepsis 
and septic shock.20-24 Thus, as had been planned 
before, we had adjusted the finding in Cox’s 
proportional hazard regression analysis with 
number of organ dysfunction.
The Cox’s proportional hazard regression 
analysis showed that there were significant risk 
differences between subjects achieved both 
targets with subjects who achieved ScvO2 target 
only and subjects who did not achieve any target; 
while there was insignificant risk difference with 
subjects achieved lactate clearance target only. 
This finding persist in the multivariate analysis. 
The result of our study was similar to study by 
Ali, et al29 which was done in general critically 
ill patients. In addition, our sub group analysis 
further supports the conclusion that achievement 
of lactate clearance target was superior to ScvO2 
target.
Lactate clearance had been extensively 
studied and shown consistently as significant 
risk factor of morality in sepsis and septic shock 
patients, although Surviving Sepsis Campaign 
2016 had not recommended a specific nominal 
target. The committee suggest normalization 
of lactate in the initial resuscitation of sepsis-
induced hypoperfusion.3 Lactate clearance cut off 
>10 was initially proposed by Ngunyen, et al10 
based on its ability to predict 60-days mortality 
of severe sepsis and septic shock patients. This 
cut-off had also been used in other similar study 
and revealed consistent result.8,12 Moreover, in 
group of patients who achieved lactate clearance 
target, there were decrease level of biomarkers 
(including inflammation, coagulation and 
apoptosis parameters, i.e. IL-6, IL-8, IL-10, IL-
1ra, tumor necrosis factor-alpha, intercellular 
adhesion molecule-1, high mobility group box-1, 
d-dimer and caspase-3) compared to patients who 
did not achieve lactate clearance target. Those 
biomarkers were related to the pathogenesis of 
multi organ dysfunction and mortality in sepsis.30 
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Thus, the ability of lactate clearance to predict 
survival of sepsis and septic shock patients is 
biologically plausible.
The inability in addition of ScvO2 target to 
lactate clearance target to predict mortality can 
be elaborated by several limitation of ScvO2 use. 
Three studies concluded that ScvO2 has poor 
correlation with mixed venous oxygen saturation 
(SvO2), which was the actual parameter that 
physiologically describes balance between 
oxygen delivery and consumption. Moreover, 
ScvO2 reflects mixture of O2 concentration 
from various organs. Low O2 concentration 
from certain organs can be masked by high O2 
concentration from another organs. Thus, ScvO2 
cannot reflect regional perfusion condition, 
including cerebral perfusion.31-35 However, our 
study showed lower mortality risk in group 
which achieved ScvO2 target only compared 
to group which did not achieve any targets, 
reflecting the role of ScvO2 as an endpoint in 
resuscitations. This finding is in accordance with 
recommendation of Surviving Sepsis Campaign 
about the 6 hours of sepsis bundles that did not 
suggest routine measurement of ScvO2, but as 
an option method for reassessment of volume 
status in persistent hypotension after initial 
fluid administration or if initial lactate was >4 
mmol/L.16 The superiority of lactate clearance 
to ScvO2 in predicting early mortality can figure 
the limitation of ScvO2 as one only indicator 
of oxygen delivery and consumption versus 
lactate clearance which is a biological reflection 
of general oxygen homeostasis of the host and 
adequacy of resuscitation process.36
Our study was a retrospective cohort study, 
with the limitations of retrospective cohort study. 
However, study was done from Intensive Care 
Unit medical records with detail history notes 
on patients clinical and laboratory progress 
that suffices to extract data needed for this 
study. Another limitation of our study was the 
unbalanced number of subjects in the four groups 
despite the total subjects meet the minimum 
sample size required for statistical analysis. 
However, the accordance of this study to the 
results of previous other sepsis studies with 
different setting and objectives, will not cause 
bias on findings of this study.
CONCLUSION
In patients with sepsis and septic shock, 
achievement of lactate clearance and ScvO2 
targets was associated with similar early 
mortality risk compared lactate clearance target 
only. However, it was associated with lower early 
mortality risk compared with ScvO2 target only. 
In cases of limited health care resources, we thus 
suggest the priority of choosing lactate clearance 
as a microcirculation resuscitation endpoint.
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